134 related articles for article (PubMed ID: 32855746)
1. Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.
Ma X; Xue H; Zhong J; Feng B; Zuo Y
Dis Markers; 2020; 2020():5327378. PubMed ID: 32855746
[TBL] [Abstract][Full Text] [Related]
2. Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients.
Fang C; Li JJ; Deng T; Li BH; Geng PL; Zeng XT
Med Sci Monit; 2019 May; 25():3298-3302. PubMed ID: 31054253
[TBL] [Abstract][Full Text] [Related]
3. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
[TBL] [Abstract][Full Text] [Related]
4. Combined Detection of ACTN4 and SCC-Ag is a Promising Serological Biomarker for Cervical Intraepithelial Neoplasia 3 or Worse: A Case-Control Study.
Zhu B; Dong B; Hong S; Wang M; Dai W; Zheng Q; Wu D; Cao Y
Risk Manag Healthc Policy; 2020; 13():2677-2687. PubMed ID: 33244281
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.
Kakuya T; Mori T; Yoshimoto S; Watabe Y; Miura N; Shoji H; Onidani K; Shibahara T; Honda K
Int J Oral Maxillofac Surg; 2017 Aug; 46(8):968-976. PubMed ID: 28385383
[TBL] [Abstract][Full Text] [Related]
6. Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
Ding XZ; Zhang SQ; Deng XL; Qiang JH
Technol Cancer Res Treat; 2021; 20():1533033821990060. PubMed ID: 33550924
[TBL] [Abstract][Full Text] [Related]
7. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
8. Serum human kallikrein 7 represents a new marker for cervical cancer.
Li W; Zhao Y; Ren L; Wu X
Med Oncol; 2014 Oct; 31(10):208. PubMed ID: 25182706
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
Luo Q; Wang H; Li J
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
[TBL] [Abstract][Full Text] [Related]
11. Serum Tie-1 is a Valuable Marker for Predicting the Progression and Prognosis of Cervical Cancer.
Bai R; Diao B; Li K; Xu X; Yang P
Pathol Oncol Res; 2021; 27():1610006. PubMed ID: 34975347
[No Abstract] [Full Text] [Related]
12. Expression level of miRNA-210-3p in cervical cancer and its prognostic potential.
Shao MX; Qu AZ; Wang YQ; Zhong YY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6583-6588. PubMed ID: 32633346
[TBL] [Abstract][Full Text] [Related]
13. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
14. Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer.
Xu X; Wei S; Chen Y; Yu D; Wang X; Dong X
Dis Markers; 2020; 2020():8493796. PubMed ID: 32908616
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
16. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
An HT; Yoo S; Ko J
Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
[TBL] [Abstract][Full Text] [Related]
17. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
Gaarenstroom KN; Bonfrer JM; Kenter GG; Korse CM; Hart AA; Trimbos JB; Helmerhorst TJ
Cancer; 1995 Sep; 76(5):807-13. PubMed ID: 8625184
[TBL] [Abstract][Full Text] [Related]
19. P27 as a prognostic factor of early cervical carcinoma.
Bouda J; Hes O; Koprivova M; Pesek M; Svoboda T; Boudova L
Int J Gynecol Cancer; 2013 Jan; 23(1):164-9. PubMed ID: 23221604
[TBL] [Abstract][Full Text] [Related]
20. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]